Genetic Testing Leader Ambry Genetics is a long-standing leader in clinical genomic testing with a growing database and collaborations with academic, corporate, and pharmaceutical partners. Sales opportunities exist in expanding partnerships for diagnostic panels, data-driven insights, and co-developed tests that leverage their extensive genetic knowledge.

Tempus Synergy As a Tempus company, Ambry Genetics has potential cross-sell opportunities with Tempus AI capabilities and platforms, enabling integrated genomic testing with advanced analytics for personalized treatment, clinical decision support, and expanded test menus.

CARE Program Edge Ambry’s CARE program won industry recognition as the best overall health informatics solution, signaling a strong value proposition around comprehensive risk assessment and education. This presents upsell paths for health systems and payer programs seeking robust health informatics and patient education tools.

Strategic Partners Recent and ongoing collaborations, including BiosLife integration and Child Neurology Foundation partnerships, indicate appetite for strategic alliances to broaden reach in hereditary cancer screening and pediatric neurology diagnostics, offering co-marketing and joint sales motions.

Fraud & Trust There is a detectable risk of employment recruitment fraud. Emphasize trust signals, verified channels, and clear credentialing in outbound outreach to maintain credibility with prospective clients and partners while ensuring compliant engagement practices.